Lin Zhang

Lin Zhang is a skilled research scientist with extensive experience in formulation research and bioanalytical chemistry. Zhang held the position of Postdoctoral Researcher in Dr. Christian Schöneich's Lab at The University of Kansas, focusing on polysorbate stability and degradation mechanisms. Subsequently, Zhang served as a Research Scientist and later as a Senior Research Advisor at Eli Lilly and Company, contributing to preformulation analytics and lead optimization through high-throughput screening. Prior to this, Zhang completed a Clinical Chemistry Internship at the Cleveland Clinic, specializing in LC-MS/MS method development. Zhang earned a Doctor of Philosophy (PhD) in Clinical Bioanalytical Chemistry from Cleveland State University.